Damato V, Theorell J, Al-Diwani A, Kienzler AK, et al. Rituximab abrogates aquaporin-4-specific germinal center activity in patients with neuromyelitis optica spectrum disorders. Proc Natl Acad Sci U S A 2022;119:e2121804119.
PMID: 35666871